Abstract
Objectives:
This study examined the reliability and validity of a Japanese version of the Motivation to Change Lifestyle and Health Behaviors for Dementia Risk Reduction (MCLHB-DRR) scale, which assesses the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder based on the health belief model.
Methods:
The scale was translated using Brislin’s translation model. A total of 500 Japanese adults aged 40–89 years were recruited online. The translated version was evaluated for content validity, internal consistency, and test-retest reliability over 2 weeks.
Results:
Exploratory factor analysis revealed a seven-factor model that explained 58% of the variance. Cronbach’s α was >0.7 for all seven subscales and item–total correlations were significant for all items. Confirmatory factor analysis exhibited a moderate fit, and the factor loadings were significant for all items. ICC (1,1) showed moderate test-retest reliability.
Conclusion:
The Japanese version of the MCLHB-DRR test showed high reliability and validity among Japanese older adults.
Introduction
Japan, one of the world’s most advanced super-aged societies, in which the proportion of older adults (aged 65 and above) is expected to exceed 30% by 2025 [1–3], faces a significant challenge in addressing the increase in patients with major neurocognitive disorder (i.e., dementia). Therefore, preventive policies for major neurocognitive disorder are urgently needed. Because multiple risk factors for major neurocognitive disorder have been identified, multi-domain interventions are considered more effective than individual interventions targeting a single domain [4]. For instance, 14 lifestyle factors contributing to the risk of major neurocognitive disorder have been identified, including education, hypertension, obesity, hearing loss, traumatic brain injury, alcohol misuse, smoking, depression, physical inactivity, social isolation, diabetes, air pollution, high LDL cholesterol, and vision loss. Comprehensive solutions addressing these factors could potentially prevent or delay up to 45% of dementia cases [5].
Furthermore, the life stage during which these factors contribute to the risk of major neurocognitive disorder varies [6, 7]. For example, social isolation, air pollution, and vision loss have emerged as strong risk factors in later life. In contrast, factors such as hearing loss, high LDL cholesterol level, traumatic brain injury, depression, and physical inactivity play a more prominent role in middle life. In addition, low educational attainment has been identified as a strong risk factor for major neurocognitive disorder in early life [5]. These variations indicate that the risk of major neurocognitive disorder exists throughout a person’s lifetime. Therefore, rather than implementing numerous policies focused on individual risk factors, fostering the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder at the individual level and encouraging diverse and comprehensive preventive behaviors throughout life may be a more effective strategy for the prevention of major neurocognitive disorder nationwide.
Research on disease prevention awareness has been conducted using various models, including the health belief model (HBM) [8], transtheoretical model [9], and social cognitive theory [10]. Among these, the HBM has been particularly effective in predicting future preventive behaviors [11]. Prevention awareness tests based on the HBM have been developed for several diseases, such as breast cancer [12, 13], cervical cancer [14, 15], and colorectal cancer [16, 17], showing correlations with participation rates for the screening of each disease. The HBM comprises four core components: perceived susceptibility, severity, benefits, and barriers. Additional variables, such as the overall motivation to pursue healthy behaviors [18], self-efficacy [19], and intention [20], have been proposed to expand the applicability of the model.
The Motivation to Change Lifestyle and Health Behaviors for Dementia Risk Reduction (MCLHB-DRR) scale [21] is a test assessing the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder, based on the HBM (Table 1). This test was developed through a focus group interview involving 34 middle-aged and older Australian participants [22], combined with a review of existing HBM-based literature related to breast cancer screening [12] and cognitive state assessments [23]. Based on these, 53 initial questions addressing attitudes and beliefs surrounding health and lifestyle behavior and dementia risk were formulated. These questions were refined to 27 items through reliability and validity evaluations, through an online survey involving 659 Australian participants. The reliability and validity of this test were confirmed through confirmatory factor analysis, Cronbach’s α, item–total correlations, and test-retest reliability. Additionally, the scale was translated and validated in various languages, including Chinese [24], Turkish [25], Hebrew [26], and Dutch [27].
TABLE 1
| N | | 1st | Retest |
|---|---|---|---|
| | 500 | 401 | |
| Gender | Male | 47.4% | 50.1% |
| | Female | 52.6% | 49.9% |
| Age | Male | 59.6 ± 12.0 | 59.8 ± 11.8 |
| | Female | 61.3 ± 12.6 | 61.8 ± 12.8 |
| Education | Elementary school | 1.0% | 0.7% |
| | Junior high school | 3.0% | 3.2% |
| | High school | 33.0% | 32.4% |
| | College or higher | 63.0% | 63.6% |
| Job | Retired or No job | 22.6% | 23.9% |
| | Employee | 28.6% | 28.4% |
| | Parttime | 16.2% | 14.7% |
| | Self-employed | 7.6% | 8.0% |
| | Housemaker | 19.8% | 19.0% |
| | Others | 5.2% | 6.0% |
| Medical history | Diabetes | 11.4% | 12.5% |
| | Hypertension | 25.6% | 23.9% |
| | Hyperlipidemia | 19.4% | 18.7% |
| | Cancer | 8.4% | 8.0% |
| | Cerebro/Cardiovascular disorders | 5.0% | 5.5% |
| Dementia in family | | 13.2% | 12.5% |
| Caregiving experience | | 23.4% | 21.9% |
Characteristics of study participants. (Japan, 2026).
However, studies focusing on prevention awareness of major neurocognitive disorder in Japan are limited; to the best of our knowledge, there is no test available in Japan to evaluate prevention awareness of major neurocognitive disorder. Therefore, this study aimed to develop a Japanese version of the test assessing the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder based on the HBM, and evaluate its reliability and validity among healthy older adults in Japan. Enhancing individual awareness of prevention is a crucial approach for reducing the risk of major neurocognitive disorder. Thus, it is anticipated that the development of this test will contribute to future research on prevention of major neurocognitive disorder in Japan.
Methods
Questionnaire
The Japanese version of the motivation test to change lifestyle and health behavior for preventing major neurocognitive disorder was developed by translating the original English version of the MCLHB-DRR scale. This scale consists of 27 items derived from seven components of the HBM. They include the four core subscales—perceived susceptibility (four items), perceived severity (five items), perceived benefits (four items), and perceived barriers (four items)—as well as cues to action (four items), general health motivation (four items), and self-efficacy (two items). Each item is evaluated on a five-point Likert scale ranging from “strongly disagree” (score = 1) to “strongly agree” (score = 5).
Development of the Japanese version of the MCLHB-DRR scale
The scale was translated following a revised version of the Brislin translation model. First, two researchers (NF and TK) proficient in both Japanese and English translated the original English version into Japanese. These translations were then integrated by multiple researchers (NF, TH, TK, and MM), including the two original translators. Subsequently, another researcher (MF) back-translated the integrated Japanese version into English. The researchers along with Ms. Sarang Kim, the original developer of the MCLHB-DRR test and two others (NF and TK) reviewed the back-translated English version and confirmed that there were no substantial differences from the original test.
Participants and procedure
This study was approved by the Ethics Committee of Keio University School of Medicine. All participants provided informed consent by clicking the consent button after reading the study explanation on the website. Middle-aged and older adults (40–89 years) residing in Japan and proficient in Japanese were recruited online. Participants were recruited from a panel maintained by the survey company Cross Marketing Inc. A total of 500 participants were selected, to match the gender and age distribution of the Japan’s national population demographics in 2023 [28]. Participants received incentive points issued by the company as compensation. The survey was conducted online from November 2–3, 2024. Participants completed the Japanese version of the MCLHB-DRR test, along with background information (gender, age, occupation, and years of education). To assess test-retest reliability, the same participants completed the survey two to three weeks later.
Statistical analyses
An exploratory factor analysis (EFA) was conducted to assess the internal validity of the test in terms of capturing the health belief model constructs. Prior to EFA, the Kaiser–Meyer–Olkin (KMO) coefficient was computed to determine the suitability of the data for factor analysis, and Bartlett’s test of sphericity was used to verify the robustness of the factor analysis. A KMO value of >0.6 was considered acceptable for sampling adequacy [29], and a significant Bartlett’s test (p < 0.05) indicated that factor analysis was appropriate. EFA was performed using the maximum likelihood estimation with oblique rotation. The number of factors was set to seven, corresponding to the original MCLHB-DRR subscales (see Supplementary Analysis). Following previous studies, items that had a loading <0.3 with their respective factors were removed [30].
Cronbach’s alpha and item–total correlations were calculated to assess the internal consistency of each subscale. Cronbach’s alpha was computed for each original subscale, and following the precedent, subscales with alpha values below 0.70 were considered unacceptable and items were removed [31]. In the item–total correlation analysis, items with values below 0.30 were excluded [32].
To evaluate the internal validity of the entire test, a confirmatory factor analysis (CFA) was performed using maximum likelihood estimation. To compare the internal validity with previous studies, the following five indices were examined: χ2/df, Comparative Fit Index (CFI), Goodness of Fit Index (GFI), Tucker-Lewis Index (TLI), and Root Mean Squared Error of Approximation (RMSEA). For χ2/df, values <3.0 were considered indicative of good fit and values <5.0 were considered indicative of reasonable fit [27, 33, 34]. Values of CFI and TLI >0.9 were considered indicative of adequate fit, while values >0.95 indicated good fit [33]. For RMSEA, values <0.08 considered reasonable error of approximation and <0.05 indicated close fit [35].
To assess the reliability of the test within participants, test-retest reliability was calculated. Specifically, for participants who completed both the initial and follow-up surveys, the intraclass correlation coefficient (ICC) was used to examine the between-participants consistency of the total scores for each subscale. ICC value was interpreted as follows: <0.5, poor; 0.5–0.75, moderate, 0.75–0.9, good; and >0.9 excellent [36].
All statistical analyses, except the test-retest reliability, were conducted using the results of the first survey. All analyses were performed using Python version 3.9.
Results
The demographic characteristics of the participants are presented in Table 2. Five hundred participants (male: n = 237, mean age = 59.6 ± 12.0; female: n = 263, mean age = 61.3 ± 12.6) were included in the first survey; of them, 401 (80.2% of the initial sample; male: n = 201, mean age = 59.8 ± 11.8; female: n = 200, mean age = 61.8 ± 12.8) participated in the test-retest reliability survey. None of the participants were excluded due to missing responses, as all questions required a response.
TABLE 2
| | | Factor 1 | Factor 2 | Factor 3 | Factor 4 | Factor 5 | Factor 6 | Factor 7 |
|---|---|---|---|---|---|---|---|---|
| Perceived susceptibility | Q1 | 0.897 | 0.010 | 0.027 | 0.055 | −0.033 | −0.048 | −0.019 |
| | Q2 | 0.914 | 0.015 | −0.025 | 0.020 | 0.032 | −0.024 | −0.027 |
| | Q3 | 0.915 | 0.027 | 0.026 | −0.025 | 0.031 | 0.018 | 0.018 |
| | Q4 | 0.551 | −0.050 | −0.006 | −0.120 | 0.048 | 0.278 | 0.096 |
| Perceived severity | Q5 | 0.173 | 0.162 | −0.068 | 0.205 | 0.208 | 0.304 | −0.163 |
| | Q6 | 0.089 | −0.034 | 0.126 | −0.032 | −0.085 | 0.727 | 0.095 |
| | Q7 | −0.007 | 0.176 | −0.027 | 0.188 | 0.248 | 0.533 | −0.232 |
| | Q8 | 0.025 | −0.070 | 0.134 | −0.109 | −0.002 | 0.736 | 0.137 |
| | Q9 | 0.010 | 0.187 | −0.008 | 0.150 | 0.194 | 0.493 | −0.160 |
| Perceived benefits | Q10 | −0.009 | 0.610 | −0.022 | 0.012 | 0.001 | 0.264 | 0.081 |
| | Q11 | 0.033 | 0.927 | 0.016 | −0.054 | −0.039 | 0.012 | 0.024 |
| | Q12 | 0.026 | 0.810 | 0.000 | 0.097 | 0.012 | −0.059 | 0.009 |
| | Q13 | 0.012 | 0.815 | 0.005 | 0.024 | 0.065 | −0.073 | 0.038 |
| Perceived barriers | Q14 | −0.069 | 0.126 | 0.704 | −0.119 | 0.053 | 0.038 | −0.001 |
| | Q15 | 0.101 | 0.014 | 0.775 | 0.041 | 0.003 | −0.029 | −0.095 |
| | Q16 | 0.039 | −0.060 | 0.844 | 0.051 | −0.024 | 0.068 | 0.045 |
| | Q17 | −0.045 | −0.006 | 0.843 | 0.010 | 0.041 | −0.009 | 0.009 |
| Cues to action | Q18 | 0.009 | −0.023 | 0.136 | 0.057 | 0.683 | 0.054 | −0.068 |
| | Q19 | 0.018 | 0.080 | 0.015 | −0.030 | 0.809 | −0.073 | 0.045 |
| | Q20 | 0.095 | −0.048 | −0.009 | −0.021 | 0.775 | 0.039 | 0.124 |
| | Q21 | 0.027 | 0.034 | −0.008 | 0.291 | 0.509 | −0.032 | 0.015 |
| General health motivation | Q22 | −0.055 | 0.068 | −0.002 | 0.633 | 0.112 | 0.009 | 0.077 |
| | Q23 | 0.066 | −0.052 | −0.063 | 0.796 | −0.016 | 0.072 | 0.126 |
| | Q24 | 0.004 | 0.086 | 0.046 | 0.840 | 0.000 | −0.110 | 0.048 |
| | Q25 | 0.106 | 0.035 | 0.076 | 0.619 | 0.087 | 0.050 | −0.093 |
| Self-efficacy | Q26 | 0.021 | 0.119 | −0.066 | 0.167 | 0.112 | 0.066 | 0.646 |
| | Q27 | −0.030 | 0.147 | 0.008 | 0.153 | 0.117 | 0.046 | 0.651 |
Item loadings of the exploratory factor analysis (seven-factor model) (Japan, 2026).
The KMO coefficient was 0.908. Bartlett’s test of sphericity showed significance (χ2 = 9,181, df = 351, p < 0.001). EFA conducted with seven factors explained 58.4% of the total variance and the first seven factors had eigenvalues greater than 1.0. The eigenvalue and the cumulative percentages of explained variance of the first seven factors were 2.87 (10.6%), 2.74 (20.8%), 2.59 (30.4%), 2.42 (39.4%), 2.19 (47.5%), 1.89 (54.5%) and 1.06 (58.4%). The factor loadings of each item on the detected seven-factor EFA model showed that all items loaded >0.3 on their respective factors, corresponding to the subscales in the original English scale (Table 2). No substantial cross-loadings (>0.3 on multiple factors) were observed and no items were deleted.
Cronbach’s α for each subscale was as follows: 0.904 (0.890–0.917) for perceived susceptibility; 0.792 (0.762–0.820) for perceived severity; 0.896 (0.881–0.910) for perceived benefits; 0.879 (0.860–0.895) for perceived barriers; 0.857 (0.835–0.876) for cues to action; 0.871 (0.851–0.888) for general health motivation; and 0.850 (0.822–0.874) for self-efficacy. The item–total correlations for all items ranged from 0.71 to 0.94 and were significant (Table 3, the corrected item-total correlation was also calculated. See Supplementary Table).
TABLE 3
| | Item | Item-total correlation | P-value |
|---|---|---|---|
| Perceived susceptibility | Q1 | 0.908 | P < 0.001 |
| | Q2 | 0.921 | P < 0.001 |
| | Q3 | 0.938 | P < 0.001 |
| | Q4 | 0.760 | P < 0.001 |
| Perceived severity | Q5 | 0.694 | P < 0.001 |
| | Q6 | 0.738 | P < 0.001 |
| | Q7 | 0.790 | P < 0.001 |
| | Q8 | 0.717 | P < 0.001 |
| | Q9 | 0.766 | P < 0.001 |
| Perceived benefits | Q10 | 0.778 | P < 0.001 |
| | Q11 | 0.909 | P < 0.001 |
| | Q12 | 0.907 | P < 0.001 |
| | Q13 | 0.897 | P < 0.001 |
| Perceived barriers | Q14 | 0.808 | P < 0.001 |
| | Q15 | 0.853 | P < 0.001 |
| | Q16 | 0.888 | P < 0.001 |
| | Q17 | 0.876 | P < 0.001 |
| Cues to action | Q18 | 0.812 | P < 0.001 |
| | Q19 | 0.862 | P < 0.001 |
| | Q20 | 0.864 | P < 0.001 |
| | Q21 | 0.809 | P < 0.001 |
| General health motivation | Q22 | 0.835 | P < 0.001 |
| | Q23 | 0.871 | P < 0.001 |
| | Q24 | 0.896 | P < 0.001 |
| | Q25 | 0.793 | P < 0.001 |
| Self-efficacy | Q26 | 0.933 | P < 0.001 |
| | Q27 | 0.933 | P < 0.001 |
Item–total correlations for all questionnaire items (Japan, 2026).
CFA was performed to assess the internal validity of the entire test. The fit indices indicated a marginal fit (χ2/df = 4.086, CFI = 0.896, GFI = 0.868, TLI = 0.880, RMSEA = 0.0786). All the item factor loadings were statistically significant. All combinations of the inter-subscale correlations were significant, except for the following pairs: perceived benefits and perceived barriers, perceived barriers and general health motivation, and perceived barriers and self-efficacy.
The test–retest reliability was moderate, with an ICC (1,1) of 0.514.
Discussion
In this study, we developed a 27-item questionnaire based on the HBM to assess the motivation to change the lifestyle and health behavior for preventing the neurocognitive disorder among Japanese participants by translating the MCLHB-DRR scale. To evaluate the reliability and validity of the Japanese version of the MCLHB-DRR scale, we conducted two surveys with 500 middle-aged and older adults and performed statistical analyses.
EFA revealed that a seven-factor model consistent with the original subscales explained 58.4% of total variance. All questionnaire items showed strong loadings exclusively with the factors corresponding to their respective subscales, indicating that the questionnaire adequately reflected the seven components of the HBM without any excesses or deficiencies. Additionally, Cronbach’s α and item–total correlation analyses showed that all items met the criteria, with no items rejected, confirming the high internal reliability of the questionnaire.
CFA further supported the internal validity of the questionnaire, as all items were significantly loaded with their respective subscales, and the model fit indices indicated a marginal fit. These findings suggest that the questionnaire appropriately represented the structure of the HBM. The results validated the development of the first Japanese test assessing the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder based on the HBM, and were consistent with findings from previous studies conducted in other countries (Table 4).
TABLE 4
| Author and invested country | N. of sample | Min. age | RMSEA | CFI | GFI | TLI | χ2/df |
|---|---|---|---|---|---|---|---|
| Kim (2014, Australia) | 617 | 50 | 0.047 | 0.92 | 0.92 | Nan | 2.38 |
| Oliveira (2019, UK) | 3,948 | 50 | Na | Na | Na | Na | Na |
| Zehirlioglu (2019, Turkey) | 220 | 40 | 0.061 | 0.88 | 0.84 | Na | 1.82 |
| Akyol (2020, Turkey) | 284 | 40 | Na | Na | Na | Na | Na |
| Joxhorst (2020, Netherlands) | 618 | 30 | 0.043 | 0.96 | Na | 0.95 | 2.13 |
| Witbeck (2022, America) | 477 | 18 | Na | Na | Na | Na | Na |
| Lin (2023, China) | 150 | 50 | 0.087 | 0.91 | Na | Na | Na |
| Shvedko (2023, Israel) | 328 | 50 | 0.072 | 0.87 | Na | 0.84 | 2.71 |
| This study | 500 | 45 | 0.079 | 0.90 | 0.87 | 0.88 | 4.09 |
Previous studies using dementia prevention awareness tests based on the motivation to change lifestyle and health behaviors for dementia risk reduction scale (Japan, 2026).
Compared to previous studies that proposed the removal of some items from the original questionnaire, this study recommends retaining all 27 items. For instance, in the Chinese version, items 7 and 18 were removed; in the Hebrew version, items 6, 8, and 15 were removed; and in the Dutch version, items 4, 10, 13, and 25 were removed. Even when using the original English version, item 25 was recommended for removal in a North American study, while a United Kingdom study suggested using only 10 items. These inconsistencies in item removal across studies suggest that the importance of specific questionnaire items is strongly influenced by regional, linguistic, and sample-specific biases. It is also possible that these differences are influenced by national characteristics or ethnicity.
In this study, none of the items were recommended for removal. This consistency may reflect not only cultural differences between countries, but also similarities in recruitment methods between the present study and the interviews conducted in Australia, where the original questionnaire was developed. In the present study, participants were recruited through an online survey administered to individuals registered with a research panel. This approach is comparable to that used in the original Australian interviews, which also relied on recruitment through a survey company. In contrast, subsequent studies have employed different recruitment strategies, such as random sampling of residents (Netherlands), recruitment via social media (the United States, England, and Israel), and face-to-face interviews with users of elderly services (China). In fact, although the age and gender distributions of the present sample were carefully matched to Japan’s demographic statistics, the proportion of participants with higher education was substantially greater than that of the general Japanese population (37.6% in the general population [37]. This suggests that the participants may have been relatively accustomed to responding to questionnaires and may have had greater exposure to health-related information, which may have contributed to the observed consistency.
A limitation of this study is that it was conducted through an online survey, restricting the sample to middle-aged and older adults who regularly use the Internet. Consequently, individuals who do not use the Internet, possibly owing to socioeconomic reasons, were not included in this study. In addition, the present sample had a higher proportion of individuals with higher education compared to the general Japanese population. Socioeconomic status and educational background can be related to the prevention of major neurocognitive disorder, [5, 6]; therefore, future research should examine the generalizability of these findings. Furthermore, this study did not examine the external validity of the questionnaire, such as by comparing it with other established gold standard measures or by investigating its association with actual dementia prevention behaviors. One reason for this is the lack of well-established alternative indicators in this field. Therefore, the relationship between test results and future dementia prevention behaviors should also be investigated in future studies.
In conclusion, this study developed a Japanese version of a test assessing the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder based on the seven components of the HBM, and confirmed its reliability and validity. All 27 items from the original MCLHB-DRR scale were retained without any exclusions. Future research should investigate the influence of individual characteristics on test results and examine effective policies to improve the motivation to change lifestyle and health behavior for preventing major neurocognitive disorder.
Statements
Data availability statement
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Ethics statement
The studies involving humans were approved by Ethics Committee of Keio University School of Medicine. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.
Author contributions
NF contributed to Investigation, Formal analysis, and Writing - original draft. All authors contributed to Writing - review and editing through discussions in regular meetings. MM and KT were responsible for Supervision and Project administration, and they also contributed to Conceptualization and provided Methodology guidance. All authors contributed to the article and approved the submitted version.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by AMED (Grant Number 24re0122004h0002).
Conflict of interest
The author(s) declared that they do not have any conflicts of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.ssph-journal.org/articles/10.3389/ijph.2026.1609357/full#supplementary-material
References
1.
Statistics Bureau of Japan. Population estimates (confirmed value as of July 2024, estimated value as of December 2024). Stat Bur Jpn. Available online at: https://www.stat.go.jp/data/jinsui/new.html (Accessed January 4, 2025).
2.
AraiHOuchiYTobaKEndoTShimokadoKTsubotaKet alJapan as the front‐runner of super‐aged societies: perspectives from medicine and medical care in Japan. Geriatr Gerontol Int (2015) 15(6):673–87. 10.1111/ggi.12450
3.
SuzukiT. Health status of older adults living in the community in Japan: recent changes and significance in the super‐aged society. Geriatr Gerontol Int (2018) 18(5):667–77. 10.1111/ggi.13266
4.
BarnesDEYaffeK. The projected effect of risk factor reduction on Alzheimer’s disease prevalence. Lancet Neurol (2011) 10(9):819–28. 10.1016/S1474-4422(11)70072-2
5.
LivingstonGHuntleyJLiuKYCostafredaSGSelbækGAlladiSet alDementia prevention, intervention, and care: 2024 report of the Lancet standing commission. Lancet (2024) 404(10452):572–628. 10.1016/S0140-6736(24)01296-0
6.
CadarD. A life course approach to dementia prevention. J Aging Geriatr Med (2017) 1(2). Available online at: https://discovery.ucl.ac.uk/id/eprint/1558926 (Accessed January 4, 2025).
7.
HwangPHAngTFDe Anda‐DuranILiuXLiuYGurnaniAet alExamination of potentially modifiable dementia risk factors across the adult life course: the framingham heart study. Alzheimers Dement (2023) 19(7):2975–83. 10.1002/alz.12940
8.
RosenstockIM. Why people use health services. Milbank Mem Fund Q (1966) 44(3):94–127. 10.1111/j.1468-0009.2005.00425.x
9.
VelicerWFProchaskaJOFavaJLNormanGJReddingCA. Detailed overview of the transtheoretical model. Homeostasis (1998) 38:216–33.
10.
SchunkDH. Social cognitive theory. In: HarrisKRGrahamSUrdanTMcCormickCBSinatraGMSwellerJ, editors APA educational psychology handbook, 1. American Psychological Association (2012). p. 101–23. 10.1037/13273-005
11.
CarpenterCJ. A meta-analysis of the effectiveness of health belief model variables in predicting behavior. Health Commun (2010) 25(8):661–9. 10.1080/10410236.2010.521906
12.
ChampionVL. Revised susceptibility, benefits, and barriers scale for mammography screening. Res Nurs Health (1999) 22(4):341–8. 10.1002/(sici)1098-240x(199908)22:4<341::aid-nur8>3.0.co;2-p
13.
AbedASGarcia-ValdesLTahaHAmezcua-PrietoC. Health belief model-based educational interventions for knowledge, beliefs, and intentions on mammography: a systematic review. BMC Women's Health (2025) 22:48. 10.1186/s12905-025-04218-9
14.
GuvencGAkyuzAAçikelCH. Health belief model scale for cervical cancer and pap smear test: psychometric testing. J Adv Nurs (2011) 67(2):428–37. 10.1111/j.1365-2648.2010.05450.x
15.
Al‐AniAHammouriMSultanHAl‐HuneidyLMansourAAl‐HussainiM. Factors affecting cervical screening using the health belief model during the last decade: a systematic review and meta‐analysis. Psycho‐Oncology (2024) 33(1):e6275. 10.1002/pon.6275
16.
HayJLFordJSKleinDPrimaveraLHBuckleyTRSteinTRet alAdherence to colorectal cancer screening in mammography-adherent older women. J Behav Med (2003) 26(6):553–76. 10.1023/A:1026253802962
17.
EstebsariFLatifiMGhorbanzadehSKandiZR. Health belief model in predicting screening behavior among population at risk of colorectal cancer: a systematic review. Iranian J Public Health (2025) 54(7):1411–23. 10.18502/ijph.v54i7.19147
18.
GreenLW. Editorial. Health Educ Monogr (1974) 2(4):324–5. 10.1177/109019817400200401
19.
RosenstockIMStrecherVJBeckerMH. Social learning theory and the health belief model. Health Educ Q (1988) 15(2):175–83. 10.1177/109019818801500203
20.
Saghafi-AslMAliasgharzadehSAsghari-JafarabadiM. Factors influencing weight management behavior among college students: an application of the health belief model. PLOS One (2020) 15(2):e0228058. 10.1371/journal.pone.0228058
21.
KimSSargent-CoxKCherbuinNAnsteyKJ. Development of the motivation to change lifestyle and health behaviours for dementia risk reduction scale. Dem Geriatr Cogn Disord Extra (2014) 4(2):172–83. 10.1159/000362228
22.
KimSAnsteyKSargent-CoxK. Motivations and Barriers to Lifestyle and Behaviour Change for Dementia Risk Reduction. Sydney, Australia: National Dementia Research Forum (2011).
23.
WernerP. Factors influencing intentions to seek a cognitive status examination: a study based on the health belief model. Int J Geriatr Psychiatry (2003) 18(9):787–94. 10.1002/gps.921
24.
LinRSSuJJKimSWongAKChanTWLeeSH. Psychometric properties of the Chinese version of the motivation to change lifestyle and health behaviors for dementia risk reduction scale (MCLHB-DRR) in Chinese community-dwelling older adults. Geriatr Nurs (2023) 54:237–45. 10.1016/j.gerinurse.2023.09.016
25.
ZehirliogluLErunalMAkyolMAMertHHatipogluNSKucukgucluO. Turkish version of the motivation for changing lifestyle and health behavior for reducing the risk of dementia scale. J Neurosci Nurs Turkish Version (2019) 51(3):119–24. 10.1097/JNN.0000000000000433
26.
ShvedkoAVVersolkerYEdelsteinOE. Translation and validation of the motivation to change lifestyle and health behaviours for dementia risk reduction (MCLHB-DRR) questionnaire among the general Israeli population. Int J Environ Res Public Health (2023) 20(3):2622. 10.3390/ijerph20032622
27.
JoxhorstTVrijsenJNiebuurJSmidtN. Cross-cultural validation of the motivation to change lifestyle and health behaviours for dementia risk reduction scale in the Dutch general population. BMC Public Health (2020) 20(1):788. 10.1186/s12889-020-08737-y
28.
Statistics Bureau of Japan. Population estimates as of; October 1, 2023 (Reiwa 5). Stat Bur Jpn. Available online at: https://www.stat.go.jp/data/jinsui/2023np/index.html (Accessed November 1, 2024).
29.
KaiserHF. An index of factorial simplicity. Psychometrika (1974) 39(1):31–6. 10.1007/BF02291575
30.
CostelloABOsborneJ. Best practices in exploratory factor analysis: four recommendations for getting the most from your analysis. Pract Assessment, Research, Evaluation (2005) 10(1). 10.7275/jyj1-4868
31.
TavakolMDennickR. Making sense of Cronbach's alpha. Int Journal Medical Education (2011) 2:53–5. 10.5116/ijme.4dfb.8dfd
32.
De VetHCTerweeCBMokkinkLBKnolDL. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press (2011).
33.
HuLTBentlerPM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equation Modeling: A Multidisciplinary Journal (1999) 6(1):1–55. 10.1080/10705519909540118
34.
WheatonBMuthenBAlwinDFSummersGF. Assessing reliability and stability in panel models. Sociological Methodology (1977) 8:84–136. 10.2307/270754
35.
BrowneMWCudeckR. Alternative ways of assessing model fit. Sociological Methods and Research (1992) 21(2):230–58. 10.1177/0049124192021002005
36.
KooTKLiMY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropractic Medicine (2016) 15(2):155–63. 10.1016/j.jcm.2016.02.012
37.
Statistics Bureau of Japan. 2020 Population Census: basic tabulation on employment status, industry, occupation, and education (2021). Tokyo: Statistics Bureau of Japan. Available online at: https://www.e-stat.go.jp/stat-search/files?page=1&stat_infid=000032201217 (Accessed April 8, 2026).
Summary
Keywords
dementia, health behavior, lifestyle change, motivation, questionnaire
Citation
Nakai F, Horigome T, Fujikawa M, Horie H, Mimura M and Kishimoto T (2026) Japanese version of the motivation to change lifestyle and health behaviors for dementia risk reduction scale: a cross-cultural validation. Int. J. Public Health 71:1609357. doi: 10.3389/ijph.2026.1609357
Received
24 November 2025
Revised
20 April 2026
Accepted
28 April 2026
Published
07 May 2026
Volume
71 - 2026
Edited by
Ana Ribeiro, University of Porto, Portugal
Reviewed by
Two reviewers who chose to remain anonymous
Updates
Copyright
© 2026 Nakai, Horigome, Fujikawa, Horie, Mimura and Kishimoto.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Taishiro Kishimoto, tkishimoto@keio.jp
This Original Article is part of the IJPH Special Issue “Urban Health in Transition: Advancing Evidence and Policy for Healthier Cities”
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.